Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill*

Abstract

Bayesian models of vancomycin show not only low bias, but also low precision in the critically ill. Thus, Bayesian-guided dosing of vancomycin in this population should be used cautiously.